Serious infections in patients with myasthenia gravis: population‐based cohort study-Reference-Cited by-同舟云学术

Serious infections in patients with myasthenia gravis: population‐based cohort study

Published:2020-02-17 Issue:4 Volume:27 Page:702-708
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Kassardjian C. D.¹^ORCID,Widdifield J.²³⁴,Paterson J. M.³⁴,Kopp A.⁴,Nagamuthu C.⁴,Barnett C.⁵^ORCID,Tu K.⁶,Breiner A.⁷

Affiliation:

1. Division of Neurology Department of Medicine St Michael's Hospital University of Toronto Toronto ON

2. Holland Bone & Joint Research Program Sunnybrook Health Sciences Centre Sunnybrook Research Institute Toronto ON

3. Institute of Health Policy, Management & Evaluation University of Toronto Toronto ON

4. ICES Toronto ON

5. Division of Neurology Department of Medicine Ellen and Martin Prosserman Centre for Neuromuscular Diseases University Health Network University of Toronto Toronto ON

6. Department of Community and Family Medicine North York General Hospital University Health Network Toronto ON

7. Division of Neurology Department of Medicine The Ottawa Hospital and Ottawa Hospital Research Institute Ottawa ON Canada

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14153

Reference25 articles.

1. Myasthenia Gravis

2. International consensus guidance for management of myasthenia gravis

3. Infections and the relationship to treatment in neuromuscular autoimmunity

4. Opportunistic infections in patients with idiopathic inflammatory myopathies

5. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+);Neurotherapeutics;2024-09

2. Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion;Neurological Sciences;2024-07-05

3. Myasthenia Gravis: Utilising cross-platform quantitative content analysis to uncover and validate unmet needs;2024-02-28

4. Chronic glucocorticoid management in neuromuscular disease: A survey of neuromuscular neurologists;Muscle & Nerve;2024-02-27

5. Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis;Frontiers in Neurology;2024-01-17